General Information of Drug (ID: DMMOV9U)

Drug Name
ISIS 28477 Drug Info
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
TTD Drug ID
DMMOV9U

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
GED-0301 DMTUV7L Crohn disease DD70 Phase 3 [2]
ISIS 28466 DMH96UP Discovery agent N.A. Investigative [1]
ISIS 28465 DMQ5JNT Discovery agent N.A. Investigative [1]
ISIS 28472 DMA4U2P Discovery agent N.A. Investigative [1]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Smad7 messenger RNA (Smad7 mRNA) TT0J32Z SMAD7_HUMAN Not Available [1]

References

1 US patent application no. 6,159,697, Antisense modulation of Smad7 expression.
2 A phase 1 open-label trial shows that smad7 antisense oligonucleotide (GED0301) does not increase the risk of small bowel strictures in Crohn's disease. Aliment Pharmacol Ther. 2012 Nov;36(9):850-7.